A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Medical College of Wisconsin
University of California, San Francisco
Duke University
Stanford University
Stanford University
OHSU Knight Cancer Institute
Stanford University
Washington University School of Medicine
M.D. Anderson Cancer Center